The Prognostic Value of Serum CRP in Acute Leukemia

Authors

  • Hala Alhasan Tishreen university
  • Feras Hussein Tishreen University
  • Rama Ibrahim Tishreen University

Abstract

Objective: Acute Leukemia is one of the malignant hematological disorders with an increasing incidence rate worldwide. As tumor cells stimulate liver to produce inflammatory cytokines, serum CRP levels are elevated. The prognostic significance of serum CRP as sensitive, easily analyzable, and cost-effective tumor marker in acute leukemia has been questioned. Methods: The study included 54 newly diagnosed patients with acute leukemia (30 with acute lymphoblastic leukemia and 24 with acute myeloid leukemia). CRP levels were measured by Immunoturbidemetry with using a Mindray analyser. Patients were divided into two groups based on their to serum CRP levels: Group (1) CRP ≤ 7.5 mg/L, Group (2) CRP > 7.5 mg/L. Results: Overall Survival (OS) rate was statistically higher in the Group CRP ≤ 7.5 mg/L. 84.8 %  Conclusions: Pre-treatment serum CRP levels is an important prognostic marker in acute leukemia patients, with high CRP levels indicating poor prognosis and lower survival rates. CRP can be used as a routine, cost-effective, and easily analyzable test.

Downloads

Published

2024-11-13

How to Cite

1.
Alhasan H, Feras Hussein, Rama Ibrahim. The Prognostic Value of Serum CRP in Acute Leukemia. Tuj-hlth [Internet]. 2024Nov.13 [cited 2025Jan.26];46(4):443-51. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/17462

Issue

Vol. 46 No. 4 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.